Associated Papers
Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study.
Kwon J et al.
Cancer Research and Treatment, 2022
Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis.
Penel N et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2022
Select a paper to view details